Wigzell Hans Lennart Rudolf 4
4 · Sarepta Therapeutics, Inc. · Filed Mar 10, 2021
Insider Transaction Report
Form 4
Wigzell Hans Lennart Rudolf
Director
Transactions
- Exercise/Conversion
Common Stock
2021-03-08$34.92/sh+10,000$349,200→ 26,518 total - Sale
Common Stock
2021-03-08$83.51/sh−10,000$835,100→ 16,518 total - Exercise/Conversion
Stock Option (right to buy)
2021-03-08−10,000→ 0 totalExercise: $34.92From: 2014-06-04Exp: 2023-06-04→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The shares were sold in transactions at prices ranging from 83.33 to 83.91, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.